Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Baklouti

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Pharmacokinetics|February 4, 2022
"De-Shrinking" EBEs: The Solution for Bayesian Therapeutic Drug MonitoringSarah Baklouti, Peggy Gandia, Didier Concordet
Clinical Pharmacokinetics|September 17, 2023
Multivariate Exact Discrepancy: A New Tool for PK/PD Model EvaluationSarah Baklouti, Emmanuelle Comets, Peggy Gandia, et al.
Antibiotics (Basel, Switzerland)|March 29, 2023
Hypoalbuminemia and Pharmacokinetics: When the Misunderstanding of a Fundamental Concept Leads to Repeated Errors over DecadesPeggy Gandia, Sarah Decheiver, Manon Picard, et al.
Frontiers in Pharmacology|May 17, 2021
Population Pharmacokinetic Model of Iohexol in Dogs to Estimate Glomerular Filtration Rate and Optimize Sampling TimeSarah Baklouti, Didier Concordet, Vitaliano Borromeo, et al.
The Journal of Antimicrobial Chemotherapy|July 24, 2019
Comment on: In vitro activity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam against Burkholderia cepacia complex, Burkholderia gladioli and other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patientsSarah Baklouti, Clémence Massip, Camille Mane, et al.
The Journal of Antimicrobial Chemotherapy|January 15, 2025
Navigating the complexities of azole antifungal therapy through pharmacokinetic concepts: a case of prolonged isavuconazole toxicityManon Launay, Florian Saunier, Sarah Baklouti, et al.
Therapie|June 14, 2024
[Pharmacogenetics of aminoglycoside ototoxicity: State of knowledge and practices - Recommendations of the Francophone Network of Pharmacogenetics (RNPGx)]Louis Lebreton, Benjamin Hennart, Sarah Baklouti, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 25, 2022
Evaluation of 4 quantification methods for monitoring 16 antibiotics and 1 beta-lactamase inhibitor in human serum by high-performance liquid chromatography with tandem mass spectrometry detectionPatrick Seraissol, Thomas Lanot, Sarah Baklouti, et al.
British Journal of Clinical Pharmacology|January 25, 2026
Population pharmacokinetic modelling of amoxicillin in human breast milk-A contribution from the ConcePTION projectSarah Baklouti, Virginie Rigourd, Alice Panchaud, et al.
Therapeutic Drug Monitoring|April 29, 2025
Ceftobiprole in Critically Ill Patients: Proposal for New Dosage RegimensSarah Baklouti, Camille Mané, Youssef Bennis, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Pharmacokinetics|February 4, 2022
"De-Shrinking" EBEs: The Solution for Bayesian Therapeutic Drug MonitoringSarah Baklouti, Peggy Gandia, Didier Concordet
Clinical Pharmacokinetics|September 17, 2023
Multivariate Exact Discrepancy: A New Tool for PK/PD Model EvaluationSarah Baklouti, Emmanuelle Comets, Peggy Gandia, et al.
Antibiotics (Basel, Switzerland)|March 29, 2023
Hypoalbuminemia and Pharmacokinetics: When the Misunderstanding of a Fundamental Concept Leads to Repeated Errors over DecadesPeggy Gandia, Sarah Decheiver, Manon Picard, et al.
Frontiers in Pharmacology|May 17, 2021
Population Pharmacokinetic Model of Iohexol in Dogs to Estimate Glomerular Filtration Rate and Optimize Sampling TimeSarah Baklouti, Didier Concordet, Vitaliano Borromeo, et al.
The Journal of Antimicrobial Chemotherapy|July 24, 2019
Comment on: In vitro activity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam against Burkholderia cepacia complex, Burkholderia gladioli and other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patientsSarah Baklouti, Clémence Massip, Camille Mane, et al.
The Journal of Antimicrobial Chemotherapy|January 15, 2025
Navigating the complexities of azole antifungal therapy through pharmacokinetic concepts: a case of prolonged isavuconazole toxicityManon Launay, Florian Saunier, Sarah Baklouti, et al.
Therapie|June 14, 2024
[Pharmacogenetics of aminoglycoside ototoxicity: State of knowledge and practices - Recommendations of the Francophone Network of Pharmacogenetics (RNPGx)]Louis Lebreton, Benjamin Hennart, Sarah Baklouti, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 25, 2022
Evaluation of 4 quantification methods for monitoring 16 antibiotics and 1 beta-lactamase inhibitor in human serum by high-performance liquid chromatography with tandem mass spectrometry detectionPatrick Seraissol, Thomas Lanot, Sarah Baklouti, et al.
British Journal of Clinical Pharmacology|January 25, 2026
Population pharmacokinetic modelling of amoxicillin in human breast milk-A contribution from the ConcePTION projectSarah Baklouti, Virginie Rigourd, Alice Panchaud, et al.
Therapeutic Drug Monitoring|April 29, 2025
Ceftobiprole in Critically Ill Patients: Proposal for New Dosage RegimensSarah Baklouti, Camille Mané, Youssef Bennis, et al.
Pageof 2